Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Association between glycaemic status at baseline and risk of subsequent multimorbidity cluster of cardiovascular disease and cancer in female participants

From: Influence of impaired glucose tolerance and type 2 diabetes on the multimorbidity cluster of cardiovascular disease and cancer: a post hoc analysis of the Da Qing Diabetes Prevention Outcome Study

Variable

Hazard ratios

95% confidence interval

P value

Age (years)

1.04

0.99–1.10

0.087

Smoking (yes = 1)

0.44

0.10–1.86

0.26

Obesity status (yes = 1)

1.56

0.74–3.28

0.24

Hypertension status (yes = 1)

1.40

0.67–2.94

0.36

Hypoglycaemic drugs (yes = 1)

0.66

0.27–1.64

0.37

Lipid-lowering drugs (yes = 1)

1.45

0.59–3.6

0.41

Antihypertensive drugs (yes = 1)

0.92

0.38–2.24

0.85

Glucose status at baseline

 Normal glucose tolerance

Reference

  

 Impaired glucose tolerance

2.52

0.82–7.75

0.11

 Newly diagnosed type 2 diabetes

3.95

1.29–12.07

0.016

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us